Share Capital (Tables)

9 Months Ended

Sep. 30, 2021

Disclosure of Share Capital [Line Items]

Schedule of Common Stock Outstanding Roll Forward

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:

	Issued and Outstanding
	Subordinate Voting Shares		Multiple Voting Shares			Super Voting Shares
As at December 31, 2020		178,113,221		40,289			312,031
Issuance of common shares pursuant to S-1		4,693,991
Issuance of shares under business combinations and    investments		7,290,180		—			—
Distribution of contingent consideration		612,737		—			—
Distribution of deferred shares		190,263		—			—
Issuance of shares for redemption of noncontrolling interests		136,075
Issuance of shares upon exercise of options and    warrants		977,646		—			—
Issuances of shares upon vesting of RSUs		357,756		—			—
Shares issued in association with notes payable		8,514
Shares issued for settlement of business dispute		240,000		—			—
Exchange of shares		1,763,500		(635	)		(17,000	)
As at September 30, 2021		194,383,883		39,654			295,031

10. SHARE CAPITAL (Continued)

Share-based Payment Arrangement, Option, Activity

Stock option activity is summarized as follows:

	Number of Shares			Weighted Average Exercise Price C$		Weighted Avereage Remaining Contractual Life		Aggregate Intrinsic Value
Balance as at December 31, 2020		5,664,406			11.91		4.39	$	85,408,034
Granted		1,303,143			37.44		4.26
Exercised		(699,265	)		13.13				13,566,825
Forfeited		(642,623	)		14.43
Balance as at September 30, 2021		5,625,661			17.38		3.73	$	78,129,641
Vested		3,335,293			12.66
Exercisable at September 30, 2021		2,396,807			12.41		3.66	$	41,611,631

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the nine months ended September 30, 2021 and the year ended December 31, 2020, using the following ranges of assumptions:

	September 30,	December 31,
	2021	2020
Risk-free interest rate	0.33% - 0.87%	0.31% - 1.37%
Expected dividend yield	0%	0%
Expected volatility	73%	80%
Expected option life	3 – 3.5 years	3 - 5 years

Schedule of Stock-Based Compensation Expense

The stock-based compensation expense for the three and nine months ended September 30, 2021 and 2020 was as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Stock options expense	$	3,483,587	$	2,614,273	$	9,821,525	$	8,209,557
Restricted Stock Units		1,511,255		1,821,361		4,876,655		6,999,963
Total Stock Based Compensation Expense	$	4,994,842	$	4,435,634	$	14,698,180	$	15,209,520

Summary Of Weighted Average Grant Date Fair Value And Intrinsic Value Of Options Exercised

The following table summarizes the weighted average grant date fair value and intrinsic value of options exercised for the nine months ended September 30, 2021 and 2020:

	Nine Months Ended September 30,
	2021		2020
Weighted average grant date fair value (per share) of stock option units granted (C$)		14.89		4.46
Intrinsic value of stock option units exercised, using market price at vest date (US$)	$	13,566,825	$	194,247

Restricted Stock Units

Disclosure of Share Capital [Line Items]

Non-vested Restricted Stock Shares Activity

The following table summarizes the number of non-vested RSU awards as of September 30, 2021 and December 31, 2020 and the changes during the nine months ended September 30, 2021:

	Number of Shares			Weighted Average Grant Date Fair Value (C$)
Nonvested Shares at December 31, 2020		689,340			16.77
Granted		127,137			38.21
Forfeited		(105,785	)		16.37
Vested		(357,756	)		21.56
Nonvested Shares at September 30, 2021		352,936			19.57

Summary Of Weighted Average Grant Date Fair Value And Intrinsic Value Of Options Exercised

The following table summarizes the weighted average grant date fair value of RSUs granted and total fair value of RSUs vested for the nine months ended September 30, 2021 and 2020:

	Nine Months Ended September 30,
	2021		2020
Weighted average grant date fair value (per share) of RSUs granted (C$)		38.21		12.65
Intrinsic value of RSUs vested, using market    price at vest date (US$)	$	10,813,387	$	8,955,783